BBBethlehem Bekele

Bethlehem Bekele

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bethlehem Bekele has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The role of chloride ions in serotonin transport

    by Jiahui Huang, Annika Backer, Stacy Uchendu, Bethlehem Bekele, Chan Li, Qingyang Chen, Esam A. Orabi, Robyn Stix, Jasper D. Shide, Yuan-Wei Zhang, et al.

    The human serotonin (5-HT + ) transporter SERT facilitates 5-HT + transport into cells by coupling it to Na + symport and K + antiport. Although extracellular Cl – is also essential for transport, Cl – cotransport has been disputed, raising questions about the role of Cl – ions and why they are required. We show that Cl – gradients do not impact 5-HT + accumulation, indicating that Cl – does not provide a driving force for uptake and arguing against stoichiometric Cl – symport. The presence of Cl – had only a small effect on Na + -mediated cytoplasmic pathway closure but markedly reduced the accessibility of residues in the extracellular pathway, consistent with modulation of the outward-facing states. Simulations illustrate that Cl – interacts strongly with a bound Na + ion and stabilizes helix packing on the extracellular side. We propose that Cl – acts as an essential architectural cofactor by enhancing Na + affinity and interactions between helices, thereby facilitating transport-related conformational transitions.

  • Open Access

    Mentorship as a Mechanism for Equity, Retention & Scientific Innovation in Neuroscience-related Careers

    by Bethlehem A Bekele, Zaki Alaoui, Ngum Agnes Mofor, Adejoke Elizabeth Memudu

    Despite rapid advances in neuroscience, Black scientists remain persistently underrepresented across training and career stages, reflecting structural inequities in mentorship, funding, and access to professional networks. These disparities limit not only individual career trajectories but also the formation of a strong scientific identity, thereby constraining the field’s capacity for innovation and global impact. In this perspective, we examine equitable mentorship as a critical tool for improving representation, retention, and scientific productivity in neuroscience. We define equitable mentorship as intentional, culturally responsive, and structurally supported guidance that extends beyond technical training to include career navigation, identity-affirming support, and access to networks. Drawing on evidence from the literature and personal experiences with mentorship models such as the Black in Neuro Mentorship Program, we highlight the value of collective, affinity-based, and cross-institutional approaches that distribute mentorship labor, foster belonging, and reduce the disproportionate burden placed on Black faculty and trainees. We argue that mentorship should be recognized as essential infrastructure for the neuroscience enterprise and call for institutional investment in structured, compensated mentorship programs to support Black neuroscientists and build a more equitable and innovative global workforce.

  • Open Access

    Structure-based Discovery of Conformationally Selective Inhibitors of the Serotonin Transporter

    by Isha Singh, Anubha Seth, Christian B. Billesbølle, Joao Braz, Ramona M. Rodriguiz, Kasturi Roy, Bethlehem Bekele, Veronica Craik, Xi-Ping Huang, Danila Boytsov, et al.

    SUMMARY: The serotonin transporter (SERT) removes synaptic serotonin and is the target of anti-depressant drugs. SERT adopts three conformations: outward-open, occluded, and inward-open. All known inhibitors target the outward-open state except ibogaine, which has an unusual anti-depressant profile and stabilizes the inward-open conformation. Unfortunately, ibogaine is promiscuous and cardiotoxic, limiting understanding of inward-open state ligands. We computationally docked over 200 million small molecules against the ibogaine stabilized inward-open state of SERT. Thirty-six top-ranking compounds were synthesized and thirteen inhibited with potencies ranging from 29 to 5000 nM. Structure-based optimization led to two novel inhibitors with Ki values down to 3 nM. The new molecules stabilized an outward-closed state of the transporter and had little activity against off-targets. A cryo-EM structure of one of these bound to SERT confirmed the predicted geometry. In mouse behavioral assays, both had anxiolytic and anti-depressant activity, with potencies up to 200 better than fluoxetine.